Keywords
Sjögren's disease
ESSDAI
How to Cite
Abstract
Introduction: The Chikungunya virus is an alphavirus transmitted by infected mosquitoes of the Aedes genus, causing fever, joint inflammation, and systemic symptoms.
Objectives: To investigate the impact of Chikungunya virus infection on Sjögren's syndrome activity assessed using the ESSDAI (EULAR Sjögren's Syndrome Disease Activity Index) and to identify the ESSDAI domain most affected by viral infection.
Materials and methods: This was an observational, retrospective, cross-sectional study that included patients with primary Sjögren's disease (according to ACR/EULAR 2016 criteria) aged 18 years and older who contracted Chikungunya virus infection between January 2023 and January 2025. ESSDAI scores were recorded before and after infection.
Results: Thirty-four patients with primary Sjögren's disease were included. Of these, 31 (91.2%) were female and 3 (8.8%) were male. Eleven of these patients (32.4% of the total cohort) were infected with Chikungunya. The mean age at diagnosis of Chikungunya infection was 48.78 ± 14.76 years. The results of the nonparametric analysis revealed a statistically significant increase in disease activity after Chikungunya infection, both in the ESSDAI total score and in the glandular, articular, and constitutional domains.
Conclusion: The results demonstrate that Chikungunya infection is associated with a significant increase in disease activity in patients with Sjögren's disease in the ESSDAI total score and in the glandular, articular, and constitutional domains.
References
(1) Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Transactions of the Royal Society of Tropical Medicine and Hygiene. junio de 2010;104(6):392-9.
(2) Oliveira JLD, Nogueira IA, Amaral JK, Campos LR, Mendonça MMM, Ricarte MDB, et al. Extra-articular Manifestations of Chikungunya. Rev Soc Bras Med Trop. 2023;56:e0341-2023.
(3) Chen W, Foo SS, Sims NA, Herrero LJ, Walsh NC, Mahalingam S. Arthritogenic alphaviruses: new insights into arthritis and bone pathology. Trends in Microbiology. enero de 2015;23(1):35-43.
(4) De Lima Cavalcanti TYV, Pereira MR, De Paula SO, Franca RFDO. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development. Viruses. 5 de mayo de 2022;14(5):969.
(5) Assunção-Miranda I, Cruz-Oliveira C, Da Poian AT. Molecular Mechanisms Involved in the Pathogenesis of Alphavirus-Induced Arthritis. BioMed Research International. 2013;2013:1-11.
(6) Duran AS, Beron A, Duran SS, et al. SAT0568. Rheumatological manifestations in a series of patients with chikungunya feverAnnals of the Rheumatic Diseases 2017;76:991. DOI: https://doi.org/10.1136/annrheumdis-2017-eular.2755
(7) de Carvalho JF, Kanduc D, da Silva FF, Tanay A, Lucchese A, Shoenfeld Y. Sjögren's Syndrome Associated with Chikungunya Infection: A Case Report. Rheumatol Ther. 2021 Mar;8(1):631-637. DOI: https://doi.org/10.1007/s40744-021-00281-4.
(8) Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, et al. EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide. RMD Open. 2015 Feb 20;1(1):e000022. DOI: https://doi.org/10.1136/rmdopen-2014-000022.
(9) Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017 Jan;69(1):35-45. DOI: https://doi.org/10.1002/art.39859.
(10) Amaral JK, Bilsborrow JB, Schoen RT. Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common. The American Journal of Medicine. marzo de 2020;133(3):e91-7.
(11) Rodríguez-Morales AJ, Cardona-Ospina JA, Fernanda Urbano-Garzón S, Sebastian Hurtado-Zapata J. Prevalence of Post-Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken). 2016 Dec;68(12):1849-1858. DOI: https://doi.org/10.1002/acr.22900.
(12) Schilte C, Staikovsky F, Couderc T, Madec Y, Carpentier F, Kassab S, et al. Chikungunya Virus-associated Long-term Arthralgia: A 36-month Prospective Longitudinal Study. Singh SK, editor. PLoS Negl Trop Dis. 21 de marzo de 2013;7(3):e2137.
(13) Kivity S, Arango MT, Ehrenfeld M, Tehori O, Shoenfeld Y, Anaya JM, et al. Infection and autoimmunity in Sjogren’s syndrome: A clinical study and comprehensive review. Journal of Autoimmunity. junio de 2014;51:17-22.
(14) Castro-Domínguez F, Salman-Monte TC, Ojeda F, Corzo P, Carrión-Barberá I, Garcia-Duitama IC, et al. Artritis erosiva por virus Chikungunya, caso y revisión de la literatura. Reumatología Clínica. noviembre de 2019;15(6):e119-21.
(15) Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine. 2009 Dec;76(6):654-7. DOI: https://doi.org/10.1016/j.jbspin.2009.08.005.
(16) Sepúlveda-Delgado J, Danis-Lozano R, Ocaa-Sibilla MJ, Ramirez-Valdespino JC, Cetina-Díaz JH, Bulos-Rodriguez P, et al. Role of HLA DRB1*15 and HLA DRB1*16alleles in the genetic susceptibility to develop systemic lupus erythematosus (SLE) after Chikungunya and Zika viruses infection in México[J]. Blood&Genomics, 2018, 2(4): 233-236. DOI: https://doi.org/10.46701/APJBG.2018042018127
(17) Imad HA, Matsee W, Kludkleeb S, Asawapaithulsert P, Phadungsombat J, Nakayama EE, et al. Post–Chikungunya Virus Infection Musculoskeletal Disorders: Syndromic Sequelae after an Outbreak. TropicalMed. 15 de abril de 2021;6(2):52. z
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Laura Martínez, Marcos A. Vázquez